Company Filing History:
Years Active: 2008
Title: The Innovations of Hui-Lin Wu: Advancements in Hepatitis B Research
Introduction
Hui-Lin Wu, an innovative inventor based in Taipei, Taiwan, is making significant strides in the field of medical research, particularly regarding hepatitis B. With a focus on developing solutions that enhance our understanding of chronic hepatitis infections, his work stands out in the realm of biotechnology.
Latest Patents
Wu holds a noteworthy patent for a recombinant plasmid designed for expressing hepatitis B viral antigens and virions in vivo. The patent, titled “Recombinant plasmid and method for expressing hepatitis B viral antigens and virions in vivo,” reveals a novel recombinant plasmid that utilizes an adeno-associated virus (AAV) vector alongside a replication-competent hepatitis B virus genome fragment. When hydrodynamically injected into mice, this recombinant plasmid has demonstrated persistent expression of hepatitis B viral antigens for over six months within hepatocytes. This underpins the establishment of an immuno-competent mouse model for exploring chronic hepatitis B virus infections, which can facilitate research into antiviral drug discovery and the underlying mechanisms of chronic hepatitis.
Career Highlights
Hui-Lin Wu is currently associated with National Taiwan University, a prominent research institution. His contributions in the field of hepatitis B research are both innovative and essential for developing potential treatments for chronic infections. His unique approach to utilizing recombinant plasmids exemplifies his commitment to advancing medical science and improving patient outcomes.
Collaborations
Throughout his career, Wu has collaborated with esteemed colleagues including Pei-Jer Chen and Li-Rung Huang. These partnerships reflect a collaborative spirit in the pursuit of knowledge and the development of groundbreaking medical solutions.
Conclusion
Hui-Lin Wu represents the next generation of inventors in the biotechnology field. His pioneering patent work on hepatitis B viral antigens illustrates the critical intersection of science and innovation. As he continues to contribute to vital research at National Taiwan University, his inventions hold the promise of impacting countless lives through advancements in medical therapy and understanding of chronic infections.